Mark L. Graham
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
Papers in
- Genetics 18
- Estrogen and related hormone effects 16
-
- Breast Cancer Treatment Studies 12
- Co-authors
- Lisa A. Carey (12 shared papers)Lynda Sawyer (8 shared papers)Carolyn I. Sartor (9 shared papers)Dominic T. Moore (7 shared papers)David W. Ollila (8 shared papers)Elizabeth Claire Dees (7 shared papers)Frances A. Collichio (7 shared papers)Thomas C. Spelsberg (8 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Journal of Magnetic Resonance Imaging (3 papers)American Journal of Hematology (3 papers)Breast Cancer Research and Treatment (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)
- Partner nations
- United StatesCanadaIreland
In The Last Decade
Mark L. Graham
52 papers receiving 4.4k citations
Mark L. Graham's Hit Papers
Peers
Comparison fields: 5 of 126
- Cancer Research 1.4k
- Oncology 1.6k
- Orthopedics and Sports Medicine 368
- Genetics 954
- Pathology and Forensic Medicine 453
Countries citing papers authored by Mark L. Graham
This map shows the geographic impact of Mark L. Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Graham more than expected).
Fields of papers citing papers by Mark L. Graham
This network shows the impact of papers produced by Mark L. Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Graham. The network helps show where Mark L. Graham may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark L. Graham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes Hit paper breakdown → | 2007 | 1632 |
| 2 | Evidence of Estrogen Receptors in Normal Human Osteoblast-Like Cells Hit paper breakdown → | 1988 | 991 |
| 3 | 2004 | 215 | |
| 4 | 2005 | 151 | |
| 5 | 2002 | 114 | |
| 6 | T47DCO cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancers to hormone resistance. | 1990 | 110 |
| 7 | 1997 | 105 | |
| 8 | 2018 | 103 | |
| 9 | 2002 | 99 | |
| 10 | 1997 | 74 | |
| 11 | 2000 | 60 | |
| 12 | 2019 | 58 | |
| 13 | 1989 | 57 | |
| 14 | 2006 | 54 | |
| 15 | 2020 | 53 | |
| 16 | 2007 | 52 | |
| 17 | 1984 | 52 | |
| 18 | 2004 | 46 | |
| 19 | 1987 | 45 | |
| 20 | 2006 | 40 |
About Mark L. Graham
Mark L. Graham is a scholar working on Genetics, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 53 papers that have together received 4.5k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (16 papers), Breast Cancer Treatment Studies (12 papers), Advanced Breast Cancer Therapies (7 papers), Cancer Treatment and Pharmacology (5 papers), Cancer Cells and Metastasis (4 papers), MRI in cancer diagnosis (3 papers), HER2/EGFR in Cancer Research (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (1.6k citations), Orthopedics and Sports Medicine (368 citations), Genetics (954 citations) and Pathology and Forensic Medicine (453 citations). Mark L. Graham has collaborated with scholars based in United States, Canada and Ireland. Frequent co-authors include Lisa A. Carey, Lynda Sawyer, Carolyn I. Sartor, Dominic T. Moore, David W. Ollila, Elizabeth Claire Dees, Frances A. Collichio, Thomas C. Spelsberg, Charles M. Perou and Nicholas J. Berg. Their work appears in journals such as Journal of Clinical Oncology, Journal of Magnetic Resonance Imaging, American Journal of Hematology, Breast Cancer Research and Treatment and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.